Cargando…
Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies
OBJECTIVE: To report the clinical, neuroimaging, and antibody associations in patients with autoimmune encephalitis (AE) and thymoma. METHODS: A retrospective cohort study of 43 patients was conducted. Antibody determination and immunoprecipitation to characterize novel antigens were performed using...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312280/ https://www.ncbi.nlm.nih.gov/pubmed/34301822 http://dx.doi.org/10.1212/NXI.0000000000001053 |
_version_ | 1783729117207724032 |
---|---|
author | Guasp, Mar Landa, Jon Martinez-Hernandez, Eugenia Sabater, Lidia Iizuka, Takahiro Simabukuro, Mateus Nakamura, Masataka Kinoshita, Makoto Kurihara, Masanori Kaida, Kenichi Bruna, Jordi Kapetanovic, Solange Sánchez, Pedro Ruiz-García, Raquel Naranjo, Laura Planagumà, Jesús Muñoz-Lopetegi, Amaia Bataller, Luis Saiz, Albert Dalmau, Josep Graus, Francesc |
author_facet | Guasp, Mar Landa, Jon Martinez-Hernandez, Eugenia Sabater, Lidia Iizuka, Takahiro Simabukuro, Mateus Nakamura, Masataka Kinoshita, Makoto Kurihara, Masanori Kaida, Kenichi Bruna, Jordi Kapetanovic, Solange Sánchez, Pedro Ruiz-García, Raquel Naranjo, Laura Planagumà, Jesús Muñoz-Lopetegi, Amaia Bataller, Luis Saiz, Albert Dalmau, Josep Graus, Francesc |
author_sort | Guasp, Mar |
collection | PubMed |
description | OBJECTIVE: To report the clinical, neuroimaging, and antibody associations in patients with autoimmune encephalitis (AE) and thymoma. METHODS: A retrospective cohort study of 43 patients was conducted. Antibody determination and immunoprecipitation to characterize novel antigens were performed using reported techniques. RESULTS: Patients' median age was 52 years (range: 23–88 years). Forty (93%) had neuronal surface antibodies: gamma-aminobutyric acid receptor A (GABA(A)R) (15), amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) (13), contactin-associated protein-like 2 (CASPR2) (4), leucine-rich, glioma inactivated 1 (LGI1) (3), glycine receptor (GlyR) (3), and unknown antigens (2). Concurrent antibodies against intracellular antigens occurred in 13 (30%; 9 anti–collapsin response mediator protein 5 [CRMP5]) and were more frequent in anti-AMPAR encephalitis (54% vs 20%; p = 0.037). The most common clinical presentation was encephalitis with multiple T2/fluid-attenuated inversion recovery hyperintense lesions in 23 (53%) patients (15 GABA(A)R, 5 AMPAR, and 1 unknown neuropil antibody), followed by encephalitis with peripheral nerve hyperexcitability in 7 (16%; 4 CASPR2, 2 LGI1, and 1 unknown antibody), limbic encephalitis in 6 (14%; 4 AMPAR, 1 LGI1, and 1 antibody negative), progressive encephalomyelitis with rigidity and myoclonus in 4 (9%; 3 GlyR and 1 AMPAR antibodies), and encephalitis with normal MRI in 3 (7%; AMPAR antibodies). Anti-GABA(A)R encephalitis was more prevalent in Japanese patients compared with Caucasians and other ethnicities (61% vs 16%; p = 0.003). In anti-AMPAR encephalitis, 3/4 patients with poor and 0/6 with good outcome had concurrent CRMP5 antibodies (p = 0.033). Immunoprecipitation studies identified metabotropic glutamate receptor 3 antibodies that were additionally found in 5 patients (3 with and 2 without encephalitis). CONCLUSIONS: AE in patients with thymoma include several clinical-radiologic syndromes that vary according to the associated antibodies. Anti-GABA(A)R encephalitis was the most frequent AE and occurred more frequently in Japanese patients. |
format | Online Article Text |
id | pubmed-8312280 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-83122802021-07-26 Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies Guasp, Mar Landa, Jon Martinez-Hernandez, Eugenia Sabater, Lidia Iizuka, Takahiro Simabukuro, Mateus Nakamura, Masataka Kinoshita, Makoto Kurihara, Masanori Kaida, Kenichi Bruna, Jordi Kapetanovic, Solange Sánchez, Pedro Ruiz-García, Raquel Naranjo, Laura Planagumà, Jesús Muñoz-Lopetegi, Amaia Bataller, Luis Saiz, Albert Dalmau, Josep Graus, Francesc Neurol Neuroimmunol Neuroinflamm Article OBJECTIVE: To report the clinical, neuroimaging, and antibody associations in patients with autoimmune encephalitis (AE) and thymoma. METHODS: A retrospective cohort study of 43 patients was conducted. Antibody determination and immunoprecipitation to characterize novel antigens were performed using reported techniques. RESULTS: Patients' median age was 52 years (range: 23–88 years). Forty (93%) had neuronal surface antibodies: gamma-aminobutyric acid receptor A (GABA(A)R) (15), amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) (13), contactin-associated protein-like 2 (CASPR2) (4), leucine-rich, glioma inactivated 1 (LGI1) (3), glycine receptor (GlyR) (3), and unknown antigens (2). Concurrent antibodies against intracellular antigens occurred in 13 (30%; 9 anti–collapsin response mediator protein 5 [CRMP5]) and were more frequent in anti-AMPAR encephalitis (54% vs 20%; p = 0.037). The most common clinical presentation was encephalitis with multiple T2/fluid-attenuated inversion recovery hyperintense lesions in 23 (53%) patients (15 GABA(A)R, 5 AMPAR, and 1 unknown neuropil antibody), followed by encephalitis with peripheral nerve hyperexcitability in 7 (16%; 4 CASPR2, 2 LGI1, and 1 unknown antibody), limbic encephalitis in 6 (14%; 4 AMPAR, 1 LGI1, and 1 antibody negative), progressive encephalomyelitis with rigidity and myoclonus in 4 (9%; 3 GlyR and 1 AMPAR antibodies), and encephalitis with normal MRI in 3 (7%; AMPAR antibodies). Anti-GABA(A)R encephalitis was more prevalent in Japanese patients compared with Caucasians and other ethnicities (61% vs 16%; p = 0.003). In anti-AMPAR encephalitis, 3/4 patients with poor and 0/6 with good outcome had concurrent CRMP5 antibodies (p = 0.033). Immunoprecipitation studies identified metabotropic glutamate receptor 3 antibodies that were additionally found in 5 patients (3 with and 2 without encephalitis). CONCLUSIONS: AE in patients with thymoma include several clinical-radiologic syndromes that vary according to the associated antibodies. Anti-GABA(A)R encephalitis was the most frequent AE and occurred more frequently in Japanese patients. Lippincott Williams & Wilkins 2021-07-23 /pmc/articles/PMC8312280/ /pubmed/34301822 http://dx.doi.org/10.1212/NXI.0000000000001053 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Article Guasp, Mar Landa, Jon Martinez-Hernandez, Eugenia Sabater, Lidia Iizuka, Takahiro Simabukuro, Mateus Nakamura, Masataka Kinoshita, Makoto Kurihara, Masanori Kaida, Kenichi Bruna, Jordi Kapetanovic, Solange Sánchez, Pedro Ruiz-García, Raquel Naranjo, Laura Planagumà, Jesús Muñoz-Lopetegi, Amaia Bataller, Luis Saiz, Albert Dalmau, Josep Graus, Francesc Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies |
title | Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies |
title_full | Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies |
title_fullStr | Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies |
title_full_unstemmed | Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies |
title_short | Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies |
title_sort | thymoma and autoimmune encephalitis: clinical manifestations and antibodies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312280/ https://www.ncbi.nlm.nih.gov/pubmed/34301822 http://dx.doi.org/10.1212/NXI.0000000000001053 |
work_keys_str_mv | AT guaspmar thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT landajon thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT martinezhernandezeugenia thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT sabaterlidia thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT iizukatakahiro thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT simabukuromateus thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT nakamuramasataka thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT kinoshitamakoto thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT kuriharamasanori thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT kaidakenichi thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT brunajordi thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT kapetanovicsolange thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT sanchezpedro thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT ruizgarciaraquel thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT naranjolaura thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT planagumajesus thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT munozlopetegiamaia thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT batallerluis thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT saizalbert thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT dalmaujosep thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies AT grausfrancesc thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies |